ANI Pharmaceuticals is headquartered in Baudette, Minnesota.
ANI Pharmaceuticals disclosed revenue of 614M USD for 2024 and 487M USD for 2023.
ANI Pharmaceuticals has 897 employees.
ANI Pharmaceuticals is a life science company.
ANI Pharmaceuticals was founded in 2001.
210 Main Street West,
Baudette, Minnesota
56623
United States,
(218) 634-3500
www.anipharmaceuticals.com
ANI Pharmaceuticals is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI Pharmaceuticals was formed in 2001 and is based in Baudette, Minnesota.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | 13 | 1 | - | - | 1 | - | 15 |
| vol | $166M | $164M | $381M | $711M | ||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 15 | ||||||||
| Financial | Deals |
|---|---|
|
Oppenheimer & Co. |
1 |
|
Houlihan Lokey |
1 |
|
Guggenheim Securities |
1 |
| Legal | Deals |
|---|---|
|
Hughes Hubbard & Reed |
2 |
|
Oppenheimer Wolff & Donnelly LLP |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
